Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Avenue Therapeutics Inc (ATXI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Avenue Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.130 -0.003    -2.26%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.132
+0.002
+1.538%
17:52:44 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 318,712
  • Bid/Ask: 0.121 / 0.140
  • Day's Range: 0.125 - 0.138
Avenue Therapeutics 0.130 -0.003 -2.26%

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ATXI Comments

Write your thoughts about Avenue Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
albert Garcia Blanco
albert Garcia Blanco Jan 12, 2024 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Avenue Therapeutics, a New York-based biotechnology company, announced on January 12, 2024 that it plans to increase its workforce by 300% by the end of April 2024. The company is hiring to work on a number of new projects , including: A new treatment for lung cancer Avenue Therapeutics is developing a new treatment for lung cancer that uses a combination of immunotherapy and chemotherapy. The treatment is designed to attack cancer cells more effectively and reduce the side effects of chemotherapy. A new treatment for Alzheimer's disease Avenue Therapeutics is developing a new treatment for Alzheimer's disease that uses a combination of drugs and gene therapy. The treatment is designed to reduce the buildup of amyloid plaques in the brain, which is believed to be one of the causes of the disease. A new treatment for cystic fibrosis Avenue Therapeutics is developing a new treatment for cystic fibrosis that uses a combination of gene therapy and cell therapy. Treatment is designed to correct the genetic defect that causes the disease. These projects are unique in the world for their innovative approach to the treatment of serious diseases. If successful, they could have a significant impact on the health of patients around the world. In addition to these projects, Avenue Therapeutics is also developing new treatments for other diseases, such as multiple sclerosis, rheumatoid arthritis and diabetes. The company is committed to researching new therapies that can improve patients' lives.
Sonia David
Sonia David Oct 14, 2022 6:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Forgotten password
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Mar 02, 2022 4:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
closed at 1.2 . it was a good play
Andrew Nazarov
Andrew Nazarov Mar 01, 2022 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
same as happens to mullen yesterday
Syed Waqas Hussain
Syed Waqas Hussain Mar 01, 2022 10:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello what happened to ATXI can anybody tell ?
Fly Me To the Moon
Fly Me To the Moon Mar 01, 2022 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
circuit breaker?
JJ JJ
JJ JJ Feb 28, 2022 7:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any 1 see that
Max Joseph
Max Joseph Feb 22, 2022 5:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
chapter 11 run
Harun Alkan
Harun Alkan Feb 22, 2022 5:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
please can you explain what is inside chapter11
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 31, 2022 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is Ready for a good run, bought for $0,75 I'm waiting for a run to the north, there are catalysts for the near future, with this breakthrough attempt it can go crazy.
Max Joseph
Max Joseph Apr 09, 2021 5:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fingers crossed guys , good luck to you
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review

Make Smart Decisions.
Research, evaluate, and invest with unique market insights

Volatile markets create opportunities.
Don’t miss out.

Investing Insights
Investing Insights
Investing Insights

Read More

Invest with knowledge

Leverage the wisdom of financial experts and seize market opportunities.

  • Generate investment ideas based on leading Wall Street analyst recommendations.

  • Research trending stocks using 6 unique market factors.

  • Receive market updates in our Insights Newsletter.

Why Investing Insights

5 ways to boost your research

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

Stay Ahead. Learn From the Pros.

For the stocks you research, we’ll bring you insights from

Questions & Answers

  • What is Investing Insights?

    Investing Insights is a premium service that provides you with actionable insights from thousands of financial experts that cover the US stock market. Find out which stocks Wall Street analysts, insiders, financial bloggers, hedge fund managers and individual investors are recommending. Investing Insights is available only on our website. Canadian and UK stock markets will soon be added.

  • What is "Smart Score"?

    Smart Score is a powerful scoring system that ranks stocks on a scale of 1-10 based on 6 unique market factors. Smart Score is updated every evening after the market closes, 5 days a week.

  • Can I try Investing Insights for free?

    Yes. You can try Investing Insights for 14 days free of charge.
    The trial period will be followed by a paid subscription. To avoid being charged simply contact our support to cancel the subscription before the trial period ends.
    Please notice that purchases made through PayPal might be subjected to a temporary authorization.

  • How do I cancel my Investing Insights premium subscription?

    In order to cancel your subscription, please contact our support with your registered email or reference number and one of our agents will be happy to assist you.

  • Will I get notified before my subscription renewal?

    Our subscription has automatic renewal, meaning that when you reach the subscription end date, you will be charged automatically and your subscription will be extended. You can cancel your subscription anytime by following the instructions in the answer to the "How do I cancel my Investing Insights subscription" question. The subscription will remain active for the duration of the paid period.

  • What are the available payment methods?

    We accept all major credit cards and debit cards, including Visa, Mastercard, American Express, Discover, JCB, and Diners. Additional payment options may be available in your specific location

Got more questions?

We hope you found the answers you were looking for. You can read more about Insights here. Please go to the Investing Help Center for further information.

By subscribing you agree to TipRanks' Terms and Conditions and Privacy Policy

Powered by
Continue with Google
or
Sign up with Email